GEODE CAPITAL MANAGEMENT, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$223,019
-84.0%
1,211,726
+3.8%
0.00%
Q2 2023$1,394,451
+77.3%
1,166,905
+2.5%
0.00%
Q1 2023$786,586
+103808.3%
1,138,001
+2.0%
0.00%
Q4 2022$757
-99.9%
1,115,883
+0.7%
0.00%
Q3 2022$1,141,000
+67.5%
1,107,829
+10.6%
0.00%
Q2 2022$681,000
-49.7%
1,001,597
-38.1%
0.00%
Q1 2022$1,355,000
-47.5%
1,617,707
+2.1%
0.00%
Q4 2021$2,583,000
-37.7%
1,584,988
-7.9%
0.00%
-100.0%
Q3 2021$4,149,000
+15.5%
1,721,677
+26.5%
0.00%
Q2 2021$3,592,000
+32.6%
1,360,649
+150.6%
0.00%
Q1 2021$2,709,000
+450.6%
542,954
+74.2%
0.00%
Q4 2020$492,000
+241.7%
311,618
+101.8%
0.00%
Q3 2020$144,000
-7.1%
154,3970.0%0.00%
Q2 2020$155,000
+106.7%
154,3970.0%0.00%
Q1 2020$75,000
-81.8%
154,397
-50.0%
0.00%
Q4 2019$412,000
+192.2%
308,794
+100.9%
0.00%
Q3 2019$141,000
-58.0%
153,7070.0%0.00%
Q2 2019$336,000
+160.5%
153,707
+298.4%
0.00%
Q1 2019$129,000
+50.0%
38,578
-91.6%
0.00%
Q4 2018$86,000456,8320.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders